UBS Group
PVCT.WS

UBS Group’s PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) PVCT.WS Stock Holding History

UBS Group’s Portfolio PVCT.WS Stock Details PVCT.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,926
Closed -$1K – 8414
2016
Q3 		$1K Buy
9,926
+4,390
+79% +$579 ﹤0.01% 7597
2016
Q2 		$1K Buy
5,536
+5,111
+1,203% +$1.12K ﹤0.01% 7639
2016
Q1 		$0 Buy
+425
New +$101 ﹤0.01% 8644

UBS Group's PVCT.WS Position: Q4 2016 in Review

UBS Group sold out of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) in Q4 2016, closing a stake of 9,926 shares — an estimated $1K sold.

UBS Group first reported a position in PVCT.WS in Q1 2016 and held it in 3 quarters. The position peaked at $1K in Q3 2016. 0 funds tracked by Wall St. Rank hold PVCT.WS as of Q4 2016.

  • UBS Group reported no remaining PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position as of Q4 2016 after selling out during the quarter.
  • UBS Group sold 9,926 PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) shares in Q4 2016, an estimated $1K.
  • UBS Group first reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in Q1 2016 and held it in 3 quarters.
  • UBS Group's PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position peaked at $1K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.